12 Biggest Healthcare ETFs Ready for Sector Rebound
The healthcare sector, the second-largest sector in the S&P 500, is the worst-performing group in the U.S. this year and…
XBI
SPDR S&P Biotech ETF
$82.82 +$0.97
(+1.19%)
As of 1:21:44 PM EDT | 5/24/19 | Market Open
XBI Trading Data
Open
$82.38
Low Price
$82.25
High Price
$83.42
Previous Last Price
$81.85
Bid Size
$82.8 X 200
Ask Size
$82.81 X 200
XBI Portfolio Data
AUM
$4,146,903,600
Shares
50,150
PE Ratio
14.85
Price / Book Ratio
4.91
Expense Ratio
0.35
Net Asset Value
$82.69
Volume
Volume
2,451,805
Avg. Volume (YDT)
5,019,704
Dollar Volume
$184,788,365
Weekly Avg. Volume
4,174,422
Monthly Avg. Volume
5,358,021
Quarterly Avg. Volume
5,260,802
XBI Fund Description
The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.
XBI Chart
XBI Summary
Fund Family
State Street Global Advisors
Tracks This Index
SPDR S&P Biotech ETF
Inception Date
2006-01-31
Asset Class
Equity
Asset Class Size
Biotech
XBI Classification
Region (General)
North America
Region (Specific)
US
Sector
Health Care
Equity Index
Leveraged Family
XBI Holdings
Top 10 Holdings
Array BioPharma Inc. (ARRY)
1.92%
SAGE Therapeutics Inc. (SAGE)
1.91%
Global Blood Therapeutics Inc (GBT)
1.9%
Celgene Corporation (CELG)
1.87%
Exact Sciences Corporation (EXAS)
1.82%
Mirati Therapeutics Inc. (MRTX)
1.8%
Ligand Pharmaceuticals Incorporated (LGND)
1.77%
AbbVie Inc. (ABBV)
1.72%
Gilead Sciences Inc. (GILD)
1.72%
Neurocrine Biosciences Inc. (NBIX)
1.7%
Total XBI Holdings
Total Holdings: 123
Array BioPharma Inc. (ARRY)
1.92%
SAGE Therapeutics Inc. (SAGE)
1.91%
Global Blood Therapeutics Inc (GBT)
1.9%
Celgene Corporation (CELG)
1.87%
Exact Sciences Corporation (EXAS)
1.82%
Mirati Therapeutics Inc. (MRTX)
1.8%
Ligand Pharmaceuticals Incorporated (LGND)
1.77%
AbbVie Inc. (ABBV)
1.72%
Gilead Sciences Inc. (GILD)
1.72%
Neurocrine Biosciences Inc. (NBIX)
1.7%
Alexion Pharmaceuticals Inc. (ALXN)
1.62%
Seattle Genetics Inc. (SGEN)
1.62%
ACADIA Pharmaceuticals Inc. (ACAD)
1.6%
BioMarin Pharmaceutical Inc. (BMRN)
1.6%
Ionis Pharmaceuticals Inc. (IONS)
1.59%
Vertex Pharmaceuticals Incorporated (VRTX)
1.59%
Incyte Corporation (INCY)
1.58%
Amgen Inc. (AMGN)
1.55%
Sarepta Therapeutics Inc. (SRPT)
1.52%
Immunomedics Inc. (IMMU)
1.48%
bluebird bio Inc. (BLUE)
1.47%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.47%
Portola Pharmaceuticals Inc. (PTLA)
1.47%
PTC Therapeutics Inc. (PTCT)
1.47%
Exelixis Inc. (EXEL)
1.46%
Intercept Pharmaceuticals Inc. (ICPT)
1.4%
Amicus Therapeutics Inc. (FOLD)
1.4%
Alnylam Pharmaceuticals Inc (ALNY)
1.33%
Regeneron Pharmaceuticals Inc. (REGN)
1.3%
United Therapeutics Corporation (UTHR)
1.29%
Arena Pharmaceuticals Inc. (ARNA)
1.27%
Ultragenyx Pharmaceutical Inc. (RARE)
1.26%
Biogen Inc. (BIIB)
1.25%
Viking Therapeutics Inc. (VKTX)
1.23%
Myriad Genetics Inc. (MYGN)
1.2%
Repligen Corporation (RGEN)
1.19%
Esperion Therapeutics Inc. (ESPR)
1.16%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.15%
Agios Pharmaceuticals Inc. (AGIO)
1.15%
Alkermes Plc (ALKS)
1.08%
FibroGen Inc. (FGEN)
1.06%
Enanta Pharmaceuticals Inc. (ENTA)
1.05%
Acceleron Pharma Inc (XLRN)
1.04%
Clovis Oncology Inc. (CLVS)
1.03%
Madrigal Pharmaceuticals Inc. (MDGL)
1.03%
Editas Medicine Inc. (EDIT)
1.02%
Genomic Health Inc. (GHDX)
1.02%
AnaptysBio Inc. (ANAB)
1.02%
Spark Therapeutics Inc. (ONCE)
1%
Emergent BioSolutions Inc. (EBS)
1%
Blueprint Medicines Corp. (BPMC)
0.97%
Sangamo Therapeutics Inc. (SGMO)
0.92%
CareDx Inc. (CDNA)
0.9%
Vanda Pharmaceuticals Inc. (VNDA)
0.84%
Insmed Incorporated (INSM)
0.82%
Iovance Biotherapeutics Inc (IOVA)
0.81%
REGENXBIO Inc. (RGNX)
0.81%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.77%
Heron Therapeutics Inc (HRTX)
0.74%
Invitae Corp. (NVTA)
0.7%
Fate Therapeutics Inc. (FATE)
0.66%
Allakos Inc. (ALLK)
0.66%
Radius Health Inc (RDUS)
0.65%
OPKO Health Inc. (OPK)
0.63%
Aimmune Therapeutics Inc (AIMT)
0.62%
Audentes Therapeutics Inc. (BOLD)
0.62%
Coherus BioSciences Inc. (CHRS)
0.62%
Natera Inc. (NTRA)
0.59%
Alder Biopharmaceuticals Inc. (ALDR)
0.54%
Acorda Therapeutics Inc. (ACOR)
0.54%
Halozyme Therapeutics Inc. (HALO)
0.54%
Allogene Therapeutics Inc. (ALLO)
0.53%
Cara Therapeutics Inc (CARA)
0.52%
Spectrum Pharmaceuticals Inc. (SPPI)
0.5%
Intrexon Corporation (XON)
0.5%
Atara Biotherapeutics Inc (ATRA)
0.5%
Eagle Pharmaceuticals Inc. (EGRX)
0.46%
ImmunoGen Inc. (IMGN)
0.46%
Vericel Corporation (VCEL)
0.46%
Puma Biotechnology Inc. (PBYI)
0.44%
AMAG Pharmaceuticals Inc. (AMAG)
0.42%
Flexion Therapeutics Inc. (FLXN)
0.4%
G1 Therapeutics Inc. (GTHX)
0.4%
Intellia Therapeutics Inc. (NTLA)
0.39%
Dynavax Technologies Corporation (DVAX)
0.38%
Xencor Inc. (XNCR)
0.37%
Veracyte Inc (VCYT)
0.37%
Stemline Therapeutics Inc. (STML)
0.36%
Momenta Pharmaceuticals Inc. (MNTA)
0.35%
Retrophin Inc. (RTRX)
0.35%
Epizyme Inc. (EPZM)
0.35%
Denali Therapeutics Inc. (DNLI)
0.35%
TG Therapeutics Inc. (TGTX)
0.35%
Ra Pharmaceuticals Inc. (RARX)
0.34%
CytomX Therapeutics Inc. (CTMX)
0.33%
MacroGenics Inc. (MGNX)
0.3%
ZIOPHARM Oncology Inc. (ZIOP)
0.29%
Progenics Pharmaceuticals Inc. (PGNX)
0.29%
Deciphera Pharmaceuticals Inc. (DCPH)
0.26%
Anika Therapeutics Inc. (ANIK)
0.26%
Achillion Pharmaceuticals Inc. (ACHN)
0.24%
Dicerna Pharmaceuticals Inc. (DRNA)
0.24%
Rigel Pharmaceuticals Inc. (RIGL)
0.24%
Akebia Therapeutics Inc. (AKBA)
0.23%
ArQule Inc. (ARQL)
0.21%
Inovio Pharmaceuticals Inc. (INO)
0.21%
Athenex Inc. (ATNX)
0.2%
PDL BioPharma Inc. (PDLI)
0.2%
Apellis Pharmaceuticals Inc. (APLS)
0.17%
Cytokinetics Incorporated (CYTK)
0.17%
Rocket Pharmaceuticals Inc. (RCKT)
0.17%
Prothena Corp. Plc (PRTA)
0.17%
Akcea Therapeutics Inc. (AKCA)
0.17%
Kura Oncology Inc. (KURA)
0.16%
Assembly Biosciences Inc. (ASMB)
0.15%
Five Prime Therapeutics Inc. (FPRX)
0.14%
GlycoMimetics Inc. (GLYC)
0.14%
Rhythm Pharmaceuticals Inc. (RYTM)
0.13%
BioCryst Pharmaceuticals Inc. (BCRX)
0.12%
Cyclerion TherapeuticsInc. (CYCN)
0.1%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.06%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%
XBI Technicals
Alpha
3.74
Beta
1.83
Leverage
Long
Standard Deviation
7.83
XBI Dividends
Dividend Date
2018-12-21
Latest Dividend
0.012
Annual Dividend
0.14
Annual Dividend Rate
0.14
Annual Dividend Yield
0.17
XBI Performance
YTD Return
15.4%
1 Year Return
-10.71%
3 Year Return
44%
5 Year Return
85.6%
10 Year Return
423%
XBI Related Articles
Biotech ETFs: Destinations For Investing in Innovation
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology exchange traded funds (ETFs), is up more than…
Healthcare, Biotech ETFs Plunge on Mounting Political Pressures
Healthcare stocks and sector-related exchange traded funds took a heavy blow Wednesday, trailing the broader market by a historic margin…
Tom Lydon on Yahoo Finance Live: SPY, Health Care, EM, and What to Avoid
As the capital markets were digesting a mixed salad of corporate earnings on Tuesday, there have been some notable entrees…
Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook
Healthcare companies were among the worst performing stocks Wednesday, with biotechnology sector-specific ETFs taking the brunt of the hit, after…
Biotech ETFs Conquers an Important Technical Hurdle
The SPDR S&P Biotech ETF (NYSEARCA: XBI), one of the largest biotech exchange traded funds, surged last week on news…